Feed Top Reports Pricing

⌘K

08:12:02·2d

SECFiling

SEC Form DEF 14A filed by Blackbaud Inc.

BLKB· Blackbaud Inc.

Technology

Full content unavailable. See the original source below.

Original source

Companies

BLKB
Blackbaud Inc.
Technology

Recent analyst ratings

Oct 31UpdateRobert W. Baird$80.00
Jun 5UpdateRaymond James$88.00
May 4UpdateRobert W. Baird$84.00
Feb 23UpdateStifel$70.00
Jul 16UpdateStifel$75.00

Related

SEC2d
SEC Form DEFA14A filed by Blackbaud Inc.
PR8d
Blackbaud Announces Date of First Quarter FY2026 Financial Results
SEC28d
Amendment: SEC Form SCHEDULE 13G/A filed by Blackbaud Inc.
INSIDER48d
EVP, Chief Operating Officer Gregoire Kevin P. sold $100,040 worth of shares (2,000 units at $50.02), decreasing direct ownership by 1% to 135,194 units (SEC Form 4)
INSIDER51d
SVP and General Counsel Olson Jon W sold $727,779 worth of shares (15,000 units at $48.52), decreasing direct ownership by 29% to 35,939 units (SEC Form 4)
SEC55d
SEC Form 144 filed by Blackbaud Inc.
INSIDER57d
SVP and General Counsel Olson Jon W was granted 1,596 shares and covered exercise/tax liability with 2,331 shares, decreasing direct ownership by 1% to 50,939 units (SEC Form 4)
INSIDER57d
EVP & Chief Technology Officer Mcdearis Kevin sold $717,851 worth of shares (15,462 units at $46.43), covered exercise/tax liability with 4,408 shares and was granted 2,554 shares, decreasing direct ownership by 17% to 87,348 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022